ADVERTISEMENT

Sensex regains 19k level; RIL, Sun Phrama lead gains

April 02, 2013 04:41 pm | Updated November 16, 2021 10:05 pm IST - Mumbai

Rising for the fourth straight day, the BSE benchmark Sensex on Tuesday jumped by 176 points to regain 19,000-mark after two weeks on sustained buying in bluechips like RIL, Sun Pharma, L&T and SBI after government said it will continue to argue for lowering of interest rates by RBI.

Stock markets, which had of late lost vigour on concerns like RBI having little room to cut rates further, shrugged off sluggishness after Finance Minister P. Chidambaram reiterated India’s commitment to additional economic reforms and the government’s pro growth stance.

The Sensex closed 176.20 points higher, or 0.93 per cent, at 19,040.95, a level last seen on March 18. The index had gained around 183 points in past three sessions.

ADVERTISEMENT

All-round buying was seen as all 13 sectoral indices closed with gains up to 2.07 per cent. Metal, refinery, capital goods, pharma and PSU counters took lead while 23 out of 30 Sensex-based stocks closed up.

RIL jumped over 2 per cent after billionaire Ambani brothers joined hands for telecom biz. Sun Pharma and Wipro gained over 4 per cent each. L&T gained 2 per cent after its construction arm bagged orders worth Rs 3,700 crore in March.

Sterlite Ind. gained 3.8 per cent after Supreme Court refused to direct closure of Tuticorin plant and set aside Madras HC’s 2010 order on closing it down. The apex court, however, asked it to pay Rs 100 crore as compensation.

ADVERTISEMENT

“Markets rose today with benchmarks up by less than 1 per cent on the back of strong individual performances. Market focus would now be on the upcoming earnings season, government policy moves in Budget session and global developments,” said Dipen Shah, Head of PCG Research, Kotak Securities.

The 50-issue CNX Nifty of the NSE also improved further by 43.70 points or 0.77 per cent, to end at 5,748.10.

Second-line shares continued to outperformed the Sensex on heavy buying by retail investors as the BSE-Smallcap and BSE-Midcap indices closed with a rise of 2.28 per cent and 1.43 per cent respectively.

Globally, Asian shares ended mixed after reports of unexpectedly weak US factory data raised investor caution ahead of new indicators that could flag falling economic momentum.

Key benchmark indices in Hong Kong, Singapore and Taiwan rose in 0.18-0.31 per cent range while China, South Korea and Japan fell in 0.30-1.08 per cent.

Europe was trading higher in early trade with key indices in France, Germany and London moving up by over 1.0 per cent.

Turning to the local market, major gainers were Sun Pharma (4.61 pc), Wipro (4.28 pc), Sterlite Ind (3.79 pc), ONGC (2.76 pc), Jindal Steel (2.53 pc), SBI (2.37 pc), RIL (2.03 pc), Maruti (1.99 pc), Cipla (1.98 pc), L&T (1.98 pc), Tata Steel (1.70 pc), BHEL (1.68 pc), Hindalco (1.53 pc), Coal India (1.13 pc), HDFC Bank (0.99 pc) and Infosys (0.91 pc).

Auto stocks like M&M and Tata Motors also recovered after showing initial weakness post weak sales numbers, said Nidhi Saraswat, Senior Research Analyst, Bonanza Portfolio.

Sectorally, the metal index gained the most by 2.07 per cent, followed by oil and gas index (1.99 pc), capital goods index (1.88 pc) and healthcare index (1.82 pc).

“Midcaps and smallcaps are seeing fresh round of buying interest. Certain stocks in this segment may surprise with their rise in the coming days. Market analysts may fail to find out the news or reasons behind such a rise,” said Milan Bavishi, Head Research, Inventure Growth and Securities.

Total market breadth remained positive as 1,953 stocks ended higher and 827 stocks finished lower. 116 ruled steady.

Total turnover rose to Rs 1,801.06 crore from Rs 1,703.44 crore on Monday.

Meanwhile, Foreign Institutional Investors (FIIs) bought shares worth a net Rs 313.07 crore on Monday, as per provisional data from the stock exchanges.

This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
This is your last free article.

ADVERTISEMENT

ADVERTISEMENT